137 related articles for article (PubMed ID: 34034495)
1. TRIM44 facilitates ovarian cancer proliferation, migration, and invasion by inhibiting FRK.
Yu XZ; Yuan JL; Ye H; Yi K; Qie MR; Hou MM
Neoplasma; 2021 Jul; 68(4):751-759. PubMed ID: 34034495
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
[TBL] [Abstract][Full Text] [Related]
3. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
Yamada Y; Kimura N; Takayama KI; Sato Y; Suzuki T; Azuma K; Fujimura T; Ikeda K; Kume H; Inoue S
Cancer Sci; 2020 Mar; 111(3):881-890. PubMed ID: 31883420
[TBL] [Abstract][Full Text] [Related]
4. MiR-34a-5p directly targeting TRIM44 affects the biological behavior of ovarian cancer cells.
Li HL; Duan YA; Zhao N
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1250-1260. PubMed ID: 33629295
[TBL] [Abstract][Full Text] [Related]
5. Exosomal circNFIX promotes angiogenesis in ovarian cancer via miR-518a-3p/TRIM44 axis.
Ye H; Wang RY; Yu XZ; Wu YK; Yang BW; Ao MY; Xi MR; Hou MM
Kaohsiung J Med Sci; 2023 Jan; 39(1):26-39. PubMed ID: 36448712
[TBL] [Abstract][Full Text] [Related]
6. LINC00958/miR-627 signal axis regulates the proliferation, migration, and invasion of thyroid papillary carcinoma cells by TRIM44.
Li YQ; Wang LC; Li AX; Huang W; Song Y; Wang W
Kaohsiung J Med Sci; 2022 May; 38(5):415-424. PubMed ID: 35199939
[TBL] [Abstract][Full Text] [Related]
7. The Novel Target of Colorectal Carcinoma: TRIM44 Regulates Cell Migration and Invasion via Activation of CXCR4/NF-κB Signaling.
Kou T; Sha D; Wang F; He T; He X
Cell Biochem Biophys; 2021 Mar; 79(1):113-121. PubMed ID: 33151473
[TBL] [Abstract][Full Text] [Related]
8. YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44.
Li W; Chen G; Feng Z; Zhu B; Zhou L; Zhang Y; Mai J; Jiang C; Zeng J
Genes Genomics; 2021 Dec; 43(12):1413-1421. PubMed ID: 34677810
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.
Ji X; Tao R; Sun LY; Xu XL; Ling W
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3152-3165. PubMed ID: 32271433
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of
Meng F; Ding J; Xu W; Luo C; Chen X; Zhang R; Sui L; Hu Y; Liu S; Shi G; He Y; Ning X; Ma R; Huang N
Transl Cancer Res; 2022 Feb; 11(2):414-425. PubMed ID: 35281418
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of circRAD23B Exerts Antitumor Response in Colorectal Cancer via the Regulation of miR-1205/TRIM44 axis.
Han B; Wang X; Yin X
Dig Dis Sci; 2022 Feb; 67(2):504-515. PubMed ID: 33634427
[TBL] [Abstract][Full Text] [Related]
12. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
13. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
Zhang X; Li F; Zhu PL
Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
[TBL] [Abstract][Full Text] [Related]
14. TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway.
Zhou X; Yang Y; Ma P; Wang N; Yang D; Tu Q; Sun B; Xiang T; Zhao X; Hou Z; Fang X
J Neurooncol; 2019 Nov; 145(2):211-222. PubMed ID: 31605296
[TBL] [Abstract][Full Text] [Related]
15. Tripartite Motif-Containing 44 is Involved in the Tumorigenesis of Laryngeal Squamous Cell Carcinoma, and its Expression is Downregulated by Nuciferine.
Li QH; Sui LP; Zhao YH; Chen BG; Li J; Ma ZH; Hu ZH; Tang YL; Guo YX
Tohoku J Exp Med; 2021 May; 254(1):17-23. PubMed ID: 34011804
[TBL] [Abstract][Full Text] [Related]
16. Expression of TRIM44 and its correlation with TLR4 in laryngeal squamous cell carcinoma.
Bai J; Liu X; Zhang S; Dang S; Zhang Y; Zhang G
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):56-61. PubMed ID: 36227676
[TBL] [Abstract][Full Text] [Related]
17. LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway.
Chen L; Qian J; You Q; Ma J
Bioengineered; 2021 Dec; 12(2):10089-10100. PubMed ID: 34724866
[TBL] [Abstract][Full Text] [Related]
18. miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44.
Zou P; Zhu M; Lian C; Wang J; Chen Z; Zhang X; Yang Y; Chen X; Cui X; Liu J; Wang H; Wen Q; Yi J
Sci Rep; 2019 Dec; 9(1):19619. PubMed ID: 31873114
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]